Weiping Deng

6.4k total citations · 1 hit paper
98 papers, 2.2k citations indexed

About

Weiping Deng is a scholar working on Infectious Diseases, Molecular Biology and Plant Science. According to data from OpenAlex, Weiping Deng has authored 98 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 20 papers in Molecular Biology and 16 papers in Plant Science. Recurrent topics in Weiping Deng's work include SARS-CoV-2 and COVID-19 Research (16 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Weiping Deng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Weiping Deng collaborates with scholars based in China, United States and Germany. Weiping Deng's co-authors include Andreas Hochhaus, Giuseppe Saglio, Hans D. Menssen, Philipp D. le Coutre, Xuefeng Jiang, Daming Zeng, Timothy P. Hughes, Richard A. Larson, Hagop M. Kantarjian and Richard E. Clark and has published in prestigious journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Weiping Deng

90 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

2016 563 citations Andreas Hochhaus, Giuseppe Saglio et al. Leukemia profile →

Peers

Countries citing papers authored by Weiping Deng

Since Specialization

Citations

This map shows the geographic impact of Weiping Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Deng more than expected).

Fields of papers citing papers by Weiping Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiping Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Deng. The network helps show where Weiping Deng may publish in the future.

Co-authorship network of co-authors of Weiping Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Deng. A scholar is included among the top collaborators of Weiping Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Deng. Weiping Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tridentate Bromo-Substituted Porphyrin-Based Metal–Organic Framework Nanoflowers for Alkene Cyclopropanation 2025 ·ACS Applied Nano Materials ·Yufei Wang, Huan Lin, Weiping Deng, (unknown), Li Zhang	1
2	mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial 2025 ·Nature Medicine ·(unknown), Jintanat Ananworanich, (unknown), Weiping Deng, (unknown), (unknown), Yamuna Devi Paila, Boris Kandinov, (unknown), (unknown), (unknown), Carole Henry, Christine A. Shaw	5
3	Volatile organic compounds of hoary stock are responsible for suppressing downy mildew of grape in an intercropping system 2025 ·Phytopathology Research ·Weiping Deng, Fei Du, Ruowei Yang, Hua Yao, Min Yang, Xinyue Mei, Chen Ye, (unknown), Yixiang Liu, Huichuan Huang, Shusheng Zhu	0
4	Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial 2025 ·The Lancet Infectious Diseases ·Spyros Chalkias, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rahnuma Wahid, Darin K. Edwards, Jing Feng, Weiping Deng, Haiyu Zhou, (unknown), Verónica Urdaneta, Yamuna Devi Paila, Bethany Girard, Saul N. Faust, Stephen R. Walsh, Catherine A. Cosgrove, Jacqueline M. Miller, Rituparna Das	6
5	A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children 2024 ·Expert Review of Vaccines ·Frances Priddy, Spyros Chalkias, Brandon Essink, (unknown), Adam Brosz, Ivan T. Lee, Jing Feng, LaRee Tracy, Weiping Deng, (unknown), Haiyu Zhou, Avika Dixit, (unknown), Bethany Girard, (unknown), Anne Yeakey, Jacqueline M. Miller, Rituparna Das, Barbara J. Kuter	6
6	SOX9 promotes hypoxic pulmonary hypertension through stabilization of DPP4 in pulmonary artery smooth muscle cells 2024 ·Experimental Cell Research ·(unknown), (unknown), (unknown), Di Wang, Weiping Deng, Chang-Ping Hu	1
7	Alleviating soil acidification to suppress Panax notoginseng soil-borne disease by modifying soil properties and the microbiome 2024 ·Plant and Soil ·Weiping Deng, (unknown), Weicheng Peng, (unknown), Yixiang Liu, Huichuan Huang, Xinyue Mei, Min Yang, Shusheng Zhu	15
8	Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial 2024 ·The Lancet Infectious Diseases ·Amparo L. Figueroa, (unknown), (unknown), (unknown), Anne Yeakey, Weiping Deng, W. Xu, (unknown), (unknown), (unknown), Bethany Girard, Jacqueline M. Miller, Rituparna Das, Frances Priddy	1
9	Solamargine Induces Hepatocellular Carcinoma Cell Apoptosis and Ferroptosis via Regulating STAT1/MTCH1 Axis 2024 ·Biochemical Genetics ·Limei Zhang, Jinfu Wang, Weiping Deng, (unknown), (unknown), Qian Zhu	4
10	Advances in the construction of diverse SuFEx linkers 2023 ·National Science Review ·Daming Zeng, Weiping Deng, Xuefeng Jiang	80
11	Graphene oxide-doped chiral dextro-hydrogel promotes peripheral nerve repair through M2 polarization of macrophages 2023 ·Colloids and Surfaces B Biointerfaces ·Weiping Deng, Xiaohui Li, Ya Li, Zhongbing Huang, Yulin Wang, Ning Mu, Juan Wang, Tunan Chen, (unknown), Guangfu Yin, Hua Feng	7
12	Non-adherent culture method affects the proliferation and apoptosis of mesenchymal stem cells through inhibiting LINC00707 to promote RNF6-mediated QKI ubiquitination 2023 ·Experimental Cell Research ·(unknown), Weiping Deng, Hongmei Zheng, Wei Yue, (unknown), (unknown), (unknown), Runmin Guo	0
13	1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves 2023 ·Open Forum Infectious Diseases ·Dean Follmann, Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Mary Marovich, Holly Janes, Weiping Deng, Frances Priddy, Avika Dixit, Joanne E. Tomassini, Rituparna Das, Jacqueline M. Miller, Haiyu Zhou	0
14	Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial 2023 ·International Journal of Infectious Diseases ·Nima S. Hejazi, Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly Janes, Lindsey R. Baden, Hana M. El Sahly, Weiping Deng, Haiyu Zhou, Brett Leav, David C. Montefiori, Peter B. Gilbert	2
15	Expanding the clinical spectrum of adult-onset neuronal intranuclear inclusion disease 2021 ·Acta Neurologica Belgica ·Yuwen Cao, (unknown), (unknown), Chao Zhang, (unknown), Ping Zhong, (unknown), Xiaojun Huang, Weiping Deng, Jing Pan, (unknown), Qing Liu, (unknown), Benyan Zhang, (unknown), Guang Chen, Shufen Chen, Li Cao, Xinghua Luan	16
16	Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study 2018 ·Journal of Cancer Research and Clinical Oncology ·David M. Ross, Tamás Masszi, María Teresa Gómez‐Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentín García‐Gutiérrez, Norbert Gattermann, Philipp D. le Coutre, Bruno Martino, Susanne Saußele, Francis J. Giles, Jerald P. Radich, Giuseppe Saglio, Weiping Deng, Nancy Krunic, Véronique Bédoucha, Prashanth Gopalakrishna, Andreas Hochhaus	104
17	Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial breakdown → 2016 ·Leukemia ·Andreas Hochhaus, Giuseppe Saglio, Timothy P. Hughes, Richard A. Larson, D-W Kim, Surapol Issaragrisil, Philipp D. le Coutre, Gabriel Étienne, P.E. Dorlhiac‐Llacer, Richard E. Clark, Ian W. Flinn, Hirohisa Nakamae, (unknown), Weiping Deng, Darshan Dalal, Hans D. Menssen, Hagop M. Kantarjian	563
18	Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin 2013 ·Alimentary Pharmacology & Therapeutics ·Stuart C. Gordon, Eric M. Yoshida, Eric Lawitz, Bruce R. Bacon, Mark Sulkowski, Mitchell Davis, Fred Poordad, J.‐P. Bronowicki, Rafael Esteban, Vilma Sniukiene, Margaret Burroughs, Weiping Deng, Frank J. Dutko, Clifford A. Brass, Janice K. Albrecht, K. Rajender Reddy	17
19	Correlative analysis between received support, anticipated support and quality of life in retired elderly patients 2008 ·Zhonghua xingwei yixue yu naokexue zazhi ·(unknown), (unknown), Weiping Deng	1
20	Structure-based design of Aurora A & B inhibitors 2008 ·Journal of Computer-Aided Molecular Design ·Anders Poulsen, Anthony D. William, (unknown), Stéphanie Blanchard, (unknown), Weiping Deng, Noah P. Tu, (unknown), Eric T. Sun, (unknown), (unknown), (unknown), Kee Chuan Goh, Zahid Bonday	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact